A synthetic peptide developed in Russia as an analog of tuftsin, a naturally occurring immune-regulating peptide found in the heavy chain of immunoglobulin G. Selank was approved in Russia in 2009 as a prescription nasal spray for generalized anxiety disorder and neurasthenia, making it one of the few peptides with actual regulatory approval as an anxiolytic. It's primarily used for anxiety reduction, cognitive enhancement, and mood stabilization.
The reason Selank gets attention over conventional anxiolytics is because it produces anti-anxiety effects comparable to benzodiazepines without sedation, cognitive impairment, tolerance, dependence, or withdrawal. If you're dealing with anxiety, stress-related brain fog, attention issues, or just want sharper cognition under pressure, Selank is worth understanding. It's also become a go-to for situational anxiety, things like public speaking, presentations, interviews, and high-stakes social situations where you need to stay calm and sharp without feeling sedated or mentally blunted the way a benzo would. The fast onset via nasal spray makes it practical for dosing 15-30 minutes before a specific event. It's also relevant for anyone on compounds that affect mood or stress response, since it modulates the same neurotransmitter systems (GABA, serotonin, dopamine) that get disrupted under those conditions.
Selank works through several overlapping mechanisms. Its anxiolytic effects come primarily from allosteric modulation of GABA-A receptors, the same receptor system benzodiazepines target, but through a different binding mechanism. One study found that Selank caused significant changes in the expression of 45 genes involved in GABAergic neurotransmission within 1 hour of administration, and that these changes positively correlated with those produced by GABA itself. Clinical studies confirmed that its anxiolytic effect is comparable to classical benzodiazepines like diazepam and phenazepam, but without their characteristic side effects. When administered alongside diazepam under chronic stress conditions, Selank actually enhanced the anxiolytic effect, suggesting it may increase the affinity of benzodiazepines for GABA-A receptors.
Beyond GABA, Selank influences serotonin metabolism and dopamine transmission in the frontal cortex and striatum, contributing to mood stabilization, motivation, and executive function. It also increases brain-derived neurotrophic factor (BDNF) expression in the hippocampus, the protein responsible for neuron survival, synaptic plasticity, and memory formation. This BDNF effect is likely what drives the longer-term cognitive benefits people report after consistent use. Selank also inhibits enkephalin-degrading enzymes, raising levels of the body's own endogenous opioid peptides, which contributes to stress resilience and a general sense of wellbeing without producing opioid-like effects or dependence.
Because Selank is derived from tuftsin, it retains immunomodulatory properties. It modulates IL-6 expression, influences the Th1/Th2 cytokine balance, and enhances natural killer cell and phagocyte activity. This is relevant if you're immunocompromised, recovering from illness, or running immunosuppressive compounds. It's also been studied for antiviral properties, though the human data on that front is limited.
Most of the clinical research on Selank comes from Russian institutions. The English-language literature is growing but still relatively thin compared to more mainstream compounds. The human trials that do exist are promising, showing significant reductions in anxiety symptoms for generalized anxiety disorder and neurasthenia, with additional anti-asthenic (energy-boosting) effects. Animal studies are more extensive and consistently show anxiolytic, nootropic, antidepressant, and neuroprotective effects. There's no established sex-specific difference in Selank's mechanism of action, and women respond to it through the same GABAergic and serotonergic pathways. Given that women are statistically more likely to experience anxiety disorders and that hormonal fluctuations can amplify GABAergic sensitivity, Selank may actually be particularly relevant for women dealing with stress, anxiety, or cognitive fog, though direct female-specific clinical data is limited.
Selank works from the first dose. Most people feel a noticeable reduction in anxiety and an improvement in mental clarity within 15-30 minutes. It's not subtle in the way most peptides are, you'll likely feel calmer, more focused, and less reactive to stress the same day you start. This is one of the reasons it works so well for acute situations like public speaking or high-pressure meetings, you can dose before the event and feel the effect in real time.
The anxiolytic effects don't need to build up over weeks the way an SSRI would. Each dose produces its own effect. That said, with consistent daily use over 1-2 weeks, many people report that the baseline improvements in mood stability, stress resilience, and cognitive sharpness become more pronounced and sustained. The BDNF upregulation and serotonin modulation likely contribute to these longer-term benefits, but the core experience is immediate.